Announced details
Drug discovery research, pharmaceutical development, translational research, regulatory science, and nonclinical development research
The parties entered into an agreement concerning the collaborative graduate school program on 1 July 2026, establishing a relationship in which Kumamoto University and SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. jointly conduct education and research.
Located in Kumamoto City, Kumamoto Prefecture; president: Ogawa Hisao (小川 久雄). A national university corporation with the Graduate School of Pharmaceutical Sciences' doctoral program in the Drug Discovery and Life Pharmaceutical Sciences major.
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s research and development operations (the specific location is not identified in the document)
The document states that the parties aim to foster drug discovery professionals, strengthen SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s research and development capabilities, and contribute to enhancing Japan's drug discovery capabilities. No impact on sales or profit is quantified.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Drug Discovery Innovation Training Program |
| Counterparty | Kumamoto University |
| Counterparty overview | Located in Kumamoto City, Kumamoto Prefecture; president: Ogawa Hisao (小川 久雄). A national university corporation with the Graduate School of Pharmaceutical Sciences' doctoral program in the Drug Discovery and Life Pharmaceutical Sciences major. |
| Relationship with the Company | The parties entered into an agreement concerning the collaborative graduate school program on 1 July 2026, establishing a relationship in which Kumamoto University and SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. jointly conduct education and research. |
| Contract Date | 1 July 2026 |
| Launch date | 1 October 2026 (already opened) |
| Applicable area | Drug discovery research, pharmaceutical development, translational research, regulatory science, and nonclinical development research |
| Location | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s research and development operations (the specific location is not identified in the document) |
| Impact on Business Performance | The document states that the parties aim to foster drug discovery professionals, strengthen SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s research and development capabilities, and contribute to enhancing Japan's drug discovery capabilities. No impact on sales or profit is quantified. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The purpose is to create an environment where students can systematically and practically learn everything from drug discovery research through pharmaceutical development, thereby fostering highly skilled drug discovery professionals. The program is intended to integrate Kumamoto University's basic research and educational capabilities with SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.'s practical expertise, specialized personnel and research and development environment in pharmaceutical development.